Search

Competing Interests: Competing interests: JD is a practising psychotherapist; co-founder of the Council for Evidence Based Psychiatry; and secretariat member of the All-Party Parliamentary Group for Prescribed Drug Dependence. He has royalties on authored and edited books. JR is chair of the International Institute for Psychiatric Drug Withdrawal. NL is chair of the South London and Maudsley NHS Foundation Trust and chair of the National Oversight Group HOPE(S) Programme Board, a clinical model developed by Mersey Care NHS Foundation Trust to reduce the use of long term segregation sometimes experienced by autistic adults, adults with a learning disability, and children and young people; paid adviser for Kooth, the UK’s largest provider of NHS commissioned digital mental health services, and Alertacall, a housing management and digital telecare company that works to improve health and safety, with repairs reporting and to detect changing needs. SH is an officer of the All-Party Parliamentary Group for Prescribed Drug Dependence. JM declares: National Institute of Health Research programme development grant, Radar follow-up study, chief investigator, 2022-24; National Institute of Health Research programme grant REDUCE study of antidepressant discontinuation co-investigator, 2017-23; co-applicant on the RELEASE trial funded by the Medical Research Future Fund in Australia; royalties on authored and edited books; lecture fees received from Alberta Psychiatric Association, British Psychological Association, Université de Sherbrooke, Case Western Reserve University, University of Basel; co-chair person, Critical Psychiatry Network; unpaid board member of non-profit Council for Evidence Based Psychiatry. AG is a member of the Council for Evidence Based Psychiatry and secretariat member of the All-Party Parliamentary Group for Prescribed Drug Dependence. MH is a clinical fellow at University College London and a collaborating investigator on the NHMRC and MRFF funded RELEASE and RELEASE+trials in Australia investigating supported, hyperbolic tapering of antidepressants; is a co-founder of Outro Health, a digital clinic which aims to help people who want to stop taking no longer needed antidepressant medication in North America using supported, hyperbolic tapering; has received honoraria for lectures on deprescribing from NHS trusts, Washington University, and the University of Arizona. PK is a member of the NICE Clinical Guidelines Panel; is director of Kinderman Consulting; has received royalties on published work in the field of mental health; is a clinical adviser to Public Health England; has received research grants from the National Institute of Health Research, the Medical Research Council, the Economic and Social Research Council, the Wellcome Trust, the Youth Justice Board for England, various NHS trusts, the Department of Health and Social Care, the European Commission, the British Psychological Society, and the Reader Organisation; has received personal fees from the Department for Constitutional Affairs, legal counsel, BBC, Al Jazeera, Smoking Gun Media, GLG Group, True North Productions, Warrington Borough Council, and Compass Pathways. LM is co-founder of the Council for Evidence Based Psychiatry and secretariat member of the All-Party Parliamentary Group for Prescribed Drug Dependence. JW is founder of A Disorder for Everyone. RP receives research funding from the NIHR for research into polypharmacy and deprescribing. SW is current chair of the British Psychological Society Division of Counselling Psychology, for which she receives a small annual remuneration of less than £4000. All other authors have none to declare.

Competing Interests: Competing interests: None declared.